Veracyte, Inc.
US ˙ NasdaqGM ˙ US92337F1075

SecurityVCYT / Veracyte, Inc.
InstitutionDeerfield Management Company, L.p. (series C)
Latest Disclosed Ownership726,000 shares
Latest Disclosed Value $ 23,384,460
Deerfield Management Company, L.p. (series C) ownership in VCYT / Veracyte, Inc.

On May 15, 2026 - Deerfield Management Company, L.p. (series C) filed a 13F-HR form disclosing ownership of 726,000 shares of Veracyte, Inc. (US:VCYT) valued at $23,384,460 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 726,000 shares of Veracyte, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $35,348,940 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VERACYTE COM 92337F107 726,000 0 0.00 23,384 -23.49 0.2759
2026-02-17 2025-12-31 13F VERACYTE COM 92337F107 726,000 0 0.00 30,565 22.63 0.3903
2025-11-14 2025-09-30 13F VERACYTE COM 92337F107 726,000 101,000 16.16 24,924 47.53 0.3805
2025-08-14 2025-06-30 13F VERACYTE COM 92337F107 625,000 625,000 16,894 0.3066
2025-02-14 2024-12-31 13F VERACYTE COM 92337F107 0 -12,032 -100.00 0 -100.00
2024-11-14 2024-09-30 13F VERACYTE COM 92337F107 12,032 12,032 410 0.0061
2024-08-14 2024-06-30 13F VERACYTE COM 92337F107 0 -10,011 -100.00 0 -100.00
2024-05-15 2024-03-31 13F VERACYTE COM 92337F107 10,011 10,011 222 0.0039
2016-08-15 2016-06-30 13F VERACYTE COM 92337F107 0 -165,097 -100.00 0 -100.00
2016-05-16 2016-03-31 13F VERACYTE COM 92337F107 165,097 -227,050 -57.90 892 -68.40 0.0380
2016-02-16 2015-12-31 13F VERACYTE COM 92337F107 392,147 8,891 2.32 2,823 57.10 0.1144
2015-11-16 2015-09-30 13F VERACYTE COM 92337F107 383,256 0 0.00 1,797 -57.91 0.0695
2015-08-14 2015-06-30 13F VERACYTE COM 92337F107 383,256 383,256 4,269 0.1422
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.